EyePoint Pharmaceuticals Inc (EYPT)
11.84
-0.68
(-5.43%)
USD |
NASDAQ |
May 17, 16:00
11.83
-0.01
(-0.08%)
After-Hours: 20:00
EyePoint Pharmaceuticals Accounts Payable (Quarterly): 7.082M for March 31, 2024
Accounts Payable (Quarterly) Chart
Historical Accounts Payable (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 7.082M |
December 31, 2023 | 6.504M |
September 30, 2023 | 9.58M |
June 30, 2023 | 10.72M |
March 31, 2023 | 9.453M |
December 31, 2022 | 5.919M |
September 30, 2022 | 6.112M |
June 30, 2022 | 7.058M |
March 31, 2022 | 7.302M |
December 31, 2021 | 7.385M |
September 30, 2021 | 6.639M |
June 30, 2021 | 5.421M |
March 31, 2021 | 5.855M |
December 31, 2020 | 4.811M |
September 30, 2020 | 5.185M |
June 30, 2020 | 3.882M |
March 31, 2020 | 5.158M |
December 31, 2019 | 4.192M |
September 30, 2019 | 5.461M |
June 30, 2019 | 6.066M |
March 31, 2019 | 6.318M |
September 30, 2018 | 4.075M |
June 30, 2018 | 2.94M |
March 31, 2018 | 2.76M |
December 31, 2017 | 1.483M |
Date | Value |
---|---|
September 30, 2017 | 1.756M |
June 30, 2017 | 1.016M |
March 31, 2017 | 0.741M |
December 31, 2016 | 1.11M |
September 30, 2016 | 1.015M |
June 30, 2016 | 1.363M |
March 31, 2016 | 0.571M |
December 31, 2015 | 0.303M |
September 30, 2015 | 0.893M |
June 30, 2015 | 0.744M |
March 31, 2015 | 0.812M |
December 31, 2014 | 0.384M |
September 30, 2014 | 1.105M |
June 30, 2014 | 0.464M |
March 31, 2014 | 0.761M |
December 31, 2013 | 0.176M |
September 30, 2013 | 1.082M |
June 30, 2013 | 0.671M |
March 31, 2013 | 0.355M |
December 31, 2012 | 0.215M |
September 30, 2012 | 0.266M |
June 30, 2012 | 0.394M |
March 31, 2012 | 0.346M |
December 31, 2011 | 0.262M |
September 30, 2011 | 0.511M |
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
3.882M
Minimum
Jun 2020
10.72M
Maximum
Jun 2023
6.489M
Average
6.089M
Median
Accounts Payable (Quarterly) Benchmarks
Nanoviricides Inc | 0.2667M |
Bio-Path Holdings Inc | 0.457M |
GlycoMimetics Inc | 0.7555M |
Ocular Therapeutix Inc | 6.453M |
Aileron Therapeutics Inc | 1.19M |